These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 462285)

  • 1. Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
    Levenstein JH
    S Afr Med J; 1979 Apr; 55(17):656. PubMed ID: 462285
    [No Abstract]   [Full Text] [Related]  

  • 2. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1979 Jan; 55(4):114. PubMed ID: 424946
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
    Hansen M; Hansen OP; Lindholm J
    Acta Med Scand; 1977; 202(5):385-8. PubMed ID: 335794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
    Forrest WA
    Scott Med J; 1976 Jan; 21(1):28-30. PubMed ID: 1257736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW; Marshall AJ; Heaton S
    Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.
    Fidler J; Smith V; Fayers P; De Swiet M
    Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1927-30. PubMed ID: 6407638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
    Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
    Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
    Gallery ED; Saunders DM; Hunyor SN; Györy AZ
    Br Med J; 1979 Jun; 1(6178):1591-4. PubMed ID: 466138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trasicor versus methyldopa in Pakistani hypertensive patients: a comparative study of efficacy and tolerability.
    Nasir ; Burke T
    J Pak Med Assoc; 1981 Aug; 31(8):172-7. PubMed ID: 6793746
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxprenolol, methyldopa and lipids in diabetes mellitus.
    Benfield GF; Hunter KR
    Br J Clin Pharmacol; 1982 Feb; 13(2):219-22. PubMed ID: 7037030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
    Gallery ED; Ross MR; Gyory AZ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):563-6. PubMed ID: 3929874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.